SEC Form 4 · accession 0001179110-15-006864
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis E Lataif
Director
Period of report
Apr 29, 2015
Accepted (ET)
Apr 30, 2015 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF5 | Apr 29, 2015 | M | 25,000 | $10.03 | A | 59,175 | D | |
| Common Stock, $0.01 par valueF5 | Apr 29, 2015 | M | 8,000 | $13.21 | A | 67,175 | D | |
| Common Stock, $0.01 par valueF5 | Apr 29, 2015 | M | 8,000 | $12.69 | A | 75,175 | D | |
| Common Stock, $0.01 par valueF5 | Apr 29, 2015 | M | 12,000 | $18.63 | A | 87,175 | D | |
| Common Stock, $0.01 par valueF5 | Apr 29, 2015 | M | 12,000 | $7.67 | A | 99,175 | D | |
| Common Stock, $0.01 par valueF5 | Apr 29, 2015 | M | 12,000 | $9.99 | A | 111,175 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F5,F2 | $10.03 | Apr 29, 2015 | M | 25,000 | D | Sep 29, 2006 | Sep 29, 2016 | Common Stock | 25,000 | 0 | D |
| Stock Option (right to buy)F1,F5,F3 | $13.21 | Apr 29, 2015 | M | 8,000 | D | Aug 8, 2007 | Aug 9, 2016 | Common Stock | 8,000 | 0 | D |
| Stock option (right to buy)F1,F5,F3 | $12.69 | Apr 29, 2015 | M | 8,000 | D | Aug 13, 2008 | Aug 8, 2017 | Common Stock | 8,000 | 0 | D |
| Stock Option (right to buy)F4,F5,F3 | $18.63 | Apr 29, 2015 | M | 12,000 | D | Aug 12, 2009 | Aug 13, 2018 | Common Stock | 12,000 | 0 | D |
| Stock Option (right to buy)F4,F5,F3 | $7.67 | Apr 29, 2015 | M | 12,000 | D | Aug 11, 2010 | Aug 12, 2019 | Common Stock | 12,000 | 0 | D |
| Stock Option (right to buy)F4,F5,F3 | $9.99 | Apr 29, 2015 | M | 12,000 | D | Aug 10, 2011 | Aug 11, 2020 | Common Stock | 12,000 | 0 | D |
Explanation of responses
- F1Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- F2These options become exerciseable in annual 20% increments commending on the date shown in Table II, Column 6.
- F3This option becomes exerciseable in full on the date set forth in Table II, Column 6.
- F4Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F5This transaction represents shares of common stock acquired through a cash purchase stock option exercise in which the acquired shares were subsequently held by the reporting person.